This inventor holds 1 USPTO granted patent. Top assignee: Shenzhen People's Hospital. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Shumin Dong: Innovator in Colorectal Cancer Prognostics
Introduction
Shumin Dong is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of medical technology, particularly in the evaluation and prognostic prediction of colorectal cancer. His innovative work has the potential to enhance diagnostic accuracy and improve patient outcomes.
Latest Patents
Shumin Dong holds a patent for an "Apparatus for collagen evaluation and prognostic prediction of colorectal cancer and storage medium." This invention involves a computer-readable storage medium that, when executed by a processor, enables multi-photon imaging on histopathological sections. The technology allows for the extraction of various collagen feature parameters from tumor tissue regions, invasive margins, and normal tissue regions. By calculating inter-region differences and establishing a collagen feature scoring model, this invention aims to provide valuable insights into tumor microenvironments.
Career Highlights
Shumin Dong is affiliated with Shenzhen People's Hospital, where he applies his expertise in medical imaging and pathology. His work focuses on advancing the understanding of colorectal cancer through innovative imaging techniques and data analysis. His contributions have been instrumental in bridging the gap between technology and healthcare.
Collaborations
Shumin Dong collaborates with esteemed colleagues, including Botao Yan and Xiumin Liu. Together, they work on various projects aimed at improving cancer diagnostics and treatment methodologies.
Conclusion
Shumin Dong's innovative contributions to colorectal cancer prognostics exemplify the intersection of technology and medicine. His work not only enhances diagnostic capabilities but also holds promise for better patient care in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile